The Value of Genetic Information for Diabetes Risk Prediction - Differences According to Sex, Age, Family History and Obesity

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Mühlenbruch, Kristin ^a,b   Jeppesen, Charlotte ^a,b   Joost, Hans Georg ^a,b   Boeing, Heiner ^a   Schulze, Matthias B ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENDER; GENETIC RISK; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PREDICTIVE VALUE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROC CURVE; SEX FACTORS;

EID: 84877907738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064307     Document Type: Article

References (30)

1. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981-990.
2. Buijsse B, Simmons RK, Griffin SJ, Schulze MB, (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33: 46-62.
3. Schulze MB, Weikert C, Pischon T, Bergmann MM, Al-Hasani H, et al. (2009) Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 32: 2116-2119.
4. Willems SM, Mihaescu R, Sijbrands EJ, van Duijn CM, Janssens AC, (2011) A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Curr Diab Rep 11: 511-518.
5. de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, et al. (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34: 121-125.
6. van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, et al. (2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57: 3122-3128.
7. Boeing H, Korfmann A, Bergmann MM, (1999) Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 205-215.
8. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, et al. (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57: 2762-2767.
9. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, et al. (2007) An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30: 510-515.
10. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J, (1997) Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 Suppl 1: S71-81.
11. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J, (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 Suppl 1: S59-70.
12. Kroke A, Klipstein-Grobusch K, Voss S, Moseneder J, Thielecke F, et al. (1999) Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr 70: 439-447.
13. Cornelis MC, Qi L, Zhang C, Kraft P, Manson J, et al. (2009) Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med 150: 541-550.
14. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172 discussion 207-112.
16. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
17. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
18. dbSNP- Database of single nucleotide polymorphisms (SNPs) and multiple small-scale variations that include insertions/deletions, microsatellites, and non-polymorphic variants. Available: http://www.ncbi.nlm.nih.gov/snp/?SITE=NcbiHome&submit=Go. Accessed 2012 Nov.
19. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, et al. (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340: b4838.
20. Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, et al. (2005) Genetic prediction of future type 2 diabetes. PLoS Med 2: e345.
21. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, et al. (2006) Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 8: 395-400.
22. Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, et al. (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31: 2056-2061.
23. Mihaescu R, van Zitteren M, van Hoek M, Sijbrands EJ, Uitterlinden AG, et al. (2010) Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve. Am J Epidemiol 172: 353-361.
24. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359: 2220-2232.
25. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359: 2208-2219.
26. Vassy JL, Durant NH, Kabagambe EK, Carnethon MR, Rasmussen-Torvik LJ, et al. (2012) A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study. Diabetologia 55: 2604-2612.
27. Franks PW, (2012) Genetic risk scores ascertained in early adulthood and the prediction of type 2 diabetes later in life. Diabetologia 55: 2555-2558.
28. Scott RA, Langenberg C, Sharp SJ, Franks PW, Rolandsson O, et al. (2012) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56: 60-69.
29. Pencina MJ, D'Agostino RB Sr, Steyerberg EW, (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21.
30. Mühlenbruch K, Heraclides A, Steyerberg EW, Joost HG, Boeing H, et al. (2013) Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories. Eur J Epidemiol 28: 25-33.